PROBristol-Myers Squibb Company
stock57.58
-1.54 (-2.60%)
Price as of 13 Oct, 12:46 · Rate limit reached. Please try again in a minute.
Good Money Guide Pro Score
Weak
Weak investment profile
Technical Analysis
Short-Term Outlook
Bullish
3 bull · 2 bear · 0 neutral
Medium-Term Outlook
Bearish
0 bull · 4 bear · 0 neutral
Price below 50-day MA
Price below 200-day MA
Price below 12-day EMA
Price below 26-day EMA
Oversold — potential reversal up
MACD below signal line
Oversold — potential reversal up
Price near lower band — potential bounce
Volatility measure — informational only
Volume Indicators
On Balance Volume (OBV)
Volume Accumulation Distribution (VAD)
Market Statistics
Day Change
-1.54
Market Cap
124035416000
Exchange
NYSE
Sector
Health Care
Fundamentals
Rate limit reached. Please try again in a minute.
Analyst Forecast
Rate limit reached. Please try again in a minute.
Fundamental Analysis
Unable to load fundamental data
Learn about Bristol-Myers Squibb Company
What is Bristol-Myers Squibb Company?
Bristol-Myers Squibb is a global biopharmaceutical company that discovers, develops, and delivers innovative medicines for serious diseases. It specializes in areas like oncology, hematology, immunology, and cardiovascular health. By investing heavily in research and development, the company brings complex treatments to market that address significant patient needs worldwide.
Is Bristol-Myers Squibb Company a good investment?
The company offers a strong dividend yield and a deep pipeline of drug candidates, which can be attractive for income-focused investors. However, potential risks include expiring patents on key blockbuster drugs and intense competition within the pharmaceutical industry. Please note that this information is for educational purposes only and does not constitute financial advice.
How do you invest in Bristol-Myers Squibb Company?
You can invest in Bristol-Myers Squibb by purchasing shares of its stock, which trades under the ticker symbol BMY on the New York Stock Exchange. This can be done through a brokerage account or an investment app. Alternatively, you may gain exposure by investing in healthcare-focused ETFs or mutual funds that hold BMY as part of a diversified portfolio.
Educational content generated by AI — not financial advice.
Time & Sales
No trades yet.
News & Sentiment
Rate limit reached. Please try again in a minute.
Community Discussion
No posts yet for BMY — be the first to start the discussion.
Point & Figure Analysis
OHLC
Signals
as of 07 Oct 2026Targets
Famous Investors Holding BMY
Ken Griffin
3.38M sh · 0.0% of portfolio
$194.50M
NEW
Ken Griffin
2.74M sh · 0.0% of portfolio
$157.77M
NEW
Ken Griffin
880.7K sh · 0.0% of portfolio
$50.75M
NEW
Ken Griffin
691.6K sh · 0.0% of portfolio
$39.85M
NEW
Ken Fisher
173.4K sh · 0.0% of portfolio
$9.99M
NEW
Mario Gabelli
82.7K sh · 0.0% of portfolio
$4.76M
NEW
Source: SEC Form 13F, reporting period 30 Jun 2026. 45-day lag applies.